Glucagon-Like Peptide 1
Concept
Vocabulary Service
Overview
subject area of
-
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial Academic Article
-
Adverse metabolic effects of a hypercaloric, high-fat diet in rodents precede observable changes in body weight Academic Article
-
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial Academic Article
-
Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis Academic Article
-
Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data Academic Article
-
Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human Academic Article
-
Effects of GLP-1 on gastric emptying, antropyloric motility, and transpyloric flow in response to a nonnutrient liquid. Academic Article
-
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis Academic Article
-
GLP-1R Agonists Modulate Enteric Immune Responses Through the Intestinal Intraepithelial Lymphocyte GLP-1R Academic Article
-
Gastrointestinal Adverse Events of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis Academic Article
-
Glucagon-Like Peptide-1 and Blood Pressure in Young and Healthy Adults from the General Population Academic Article
-
Glucagon-Like Peptide-1 as Predictor of Body Mass Index and Dentate Gyrus Neurogenesis: Neuroplasticity and the Metabolic Milieu Academic Article
-
Healthy lifestyle and glucagon-like peptide-1 in young and healthy adults: A population-based study Academic Article
-
Immunometabolism Sentinels: Gut Surface T-Cells Regulate GLP-1 Availability Academic Article
-
Impact of GLP-1 Receptor Agonists on Major Gastrointestinal Disorders for Type 2 Diabetes Mellitus: A Mixed Treatment Comparison Meta-Analysis Academic Article
-
Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis Academic Article
-
Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis Academic Article
-
Local, exendin-(9—39)-insensitive, site of action of GLP-1 in canine ileum Academic Article
-
Metabolic endotoxemia is dictated by the type of lipopolysaccharide Academic Article
-
Metabolic, stress, and inflammatory biomarker responses to glucose administration in Fischer-344 rats: intraperitoneal vs. oral delivery Academic Article
-
Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD Academic Article
-
Newly prescribed canagliflozin vs. GLP-1 agonists was linked to amputation in older adults with type 2 DM and CVD Academic Article
-
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo Academic Article
-
Relationships of iron metabolism with insulin resistance and glucose levels in young and healthy adults Academic Article